The Illumina Genomics Forum will bring together leading visionaries to explore the brand new infrastructure of Architecting Health

The panel will generate ideas and inspiration to build the foundational building blocks needed to make genomic health equitable, informed and accountable

SAN DIEGO, September 12, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a group of leading visionaries, titled “Architecting Health’s Radically New Infrastructure”, as part of its first Illumina Genomics Forum held in San Diego of From September 28 to October 1. This main session, which takes place on friday september 30will feature renowned experts addressing fundamental challenges and opportunities facing the health sector, including knowledge of genomics, equity, public health and pathogen preparedness.

Moderated by Joao Bosco OliveiraHead of Genomics at Albert Einstein Hospital, the panel will include:

  • Abasi Ene-Obong, Founder and CEO, 54Gene
  • Stacey GabrielDirector of Genomics, Broad Institute
  • Scott Gottliebformer FDA commissioner
  • Chris WigleyCEO, Genomics England

“We are deeply touched and absolutely thrilled to have these global leaders from across the genomics and healthcare ecosystem participating in our first Illumina Genomics Forum,” said Catherine Reeves, chief marketing officer of Illumina. “Their collective vision to make genomic health a more inclusive and accessible standard of care is inspiring to all of us, and I look forward to the transformative insights, perspectives and insights they will share at the forum. .”

Illumina previously announced that the former US President barack obama will be the headliner of the forum during a fireside chat on the evening of Wednesday, September 28. Twelve years after the Affordable Care Act was passed, Obama will discuss the continued need for equity, accessibility, and smarter health care to improve the human condition. Then, on September 30, Bill Gatesco-chair of the Bill & Melinda Gates Foundation, will deliver a keynote address on the remarkable potential of genomics to change the trajectory of global health.

Other key IGF themes include:

  • How Genomics Technology is Driving More Informed, Proactive and Personalized Patient Diagnosis and Treatment in Clinics
  • Ways whole genome sequencing is revolutionizing patient care
  • The Role of Genomics in Supporting the Quadruple Goal of Health Care: Improve Population Health, Reduce Costs, Improve Patient Experience, and Improve Provider Satisfaction

Illumina Genomics Forum will take place at San Diego of From September 28 to October 1. For more information and to register for the conference, visit illuminagenomicsforum.com.

About Illumina

lllumina improves human health by unleashing the power of the genome. Our focus on innovation has enabled us to become a global leader in DNA sequencing and chip-based technologies, serving customers in the research, clinical and application markets. Our products are used for applications in life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us at TwitterFacebook, LinkedIn, Instagram and YouTube.

Investors:
Salli Schwartz
858-291-6421
[email protected]

Media:
Matt Blanco
619-490-6414
[email protected]

SOURCEIllumina, Inc.

Comments are closed.